Calapai, F.;                     Ammendolia, I.;                     Cardia, L.;                     Currò, M.;                     Calapai, G.;                     Esposito, E.;                     Mannucci, C.    
        Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database. Pharmaceutics 2023, 15, 1933.
    https://doi.org/10.3390/pharmaceutics15071933
    AMA Style
    
                                Calapai F,                                 Ammendolia I,                                 Cardia L,                                 Currò M,                                 Calapai G,                                 Esposito E,                                 Mannucci C.        
                Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database. Pharmaceutics. 2023; 15(7):1933.
        https://doi.org/10.3390/pharmaceutics15071933
    
    Chicago/Turabian Style
    
                                Calapai, Fabrizio,                                 Ilaria Ammendolia,                                 Luigi Cardia,                                 Mariaconcetta Currò,                                 Gioacchino Calapai,                                 Emanuela Esposito,                                 and Carmen Mannucci.        
                2023. "Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database" Pharmaceutics 15, no. 7: 1933.
        https://doi.org/10.3390/pharmaceutics15071933
    
    APA Style
    
                                Calapai, F.,                                 Ammendolia, I.,                                 Cardia, L.,                                 Currò, M.,                                 Calapai, G.,                                 Esposito, E.,                                 & Mannucci, C.        
        
        (2023). Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database. Pharmaceutics, 15(7), 1933.
        https://doi.org/10.3390/pharmaceutics15071933